INHALE-3: Afrezza® Combined With Insulin Degludec Versus Usual Care in Adults With Type 1 Diabetes

NCT05904743 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

141

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

BIOLOGICAL: Afrezza
BIOLOGICAL: insulin degludec
BIOLOGICAL: Rapid-acting Insulin Analog
BIOLOGICAL: Basal Insulin

Sponsor

Mannkind Corporation

Collaborators

[object Object]